FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185652955> ?p ?o ?g. }

• W2185652955 endingPage "e0138343" @default.
• W2185652955 startingPage "e0138343" @default.
• W2185652955 abstract "Tregs infusion reverts proteinuria and reduces renal lesions in most animal models of nephrotic syndrome (i.e. Buffalo/Mna, Adriamycin, Promycin, LPS). IL2 up-regulates Tregs and may be an alternative to cell-therapy in this setting. To evaluate a potential role of IL2 as Tregs inducer and proteinuria lowering agent in human nephrotic syndrome we treated 5 nephrotic patients with 6 monthly cycles of low-dose IL2 (1x106 U/m2 first month, 1.5x106 U/m2 following months). The study cohort consisted of 5 children (all boys, 11–17 years) resistant to all the available treatments (i.e. steroids, calcineurin inhibitors, mycophenolate, Rituximab). Participants had Focal Segmental Glomerulosclerosis (3 cases) or Minimal Change Nephropathy (2 cases). IL2 was safe in all but one patient who had an acute asthma attack after the first IL2 dose and did not receive further doses. Circulating Tregs were stably increased (>10%) during the whole study period in 2 cases while were only partially modified in the other two children who started with very low levels and partially responded to single IL2 Proteinuria and renal function were not modified by IL2 at any phase of the study. We concluded that low-dose IL2 given in monthly pulses is safe and modifies the levels of circulating Tregs. This drug may not be able to lower proteinuria or affect renal function in children with idiopathic nephrotic syndrome. We were unable to reproduce in humans the effects of IL2 described in rats and mice reducing de facto the interest on this drug in nephrotic syndrome.ClinicalTrials.gov NCT02455908." @default.
• W2185652955 created "2016-06-24" @default.
• W2185652955 creator A5012581184 @default.
• W2185652955 creator A5020775570 @default.
• W2185652955 creator A5031919839 @default.
• W2185652955 creator A5039683551 @default.
• W2185652955 creator A5077588620 @default.
• W2185652955 creator A5090372922 @default.
• W2185652955 creator A5090684192 @default.
• W2185652955 date "2015-09-28" @default.
• W2185652955 modified "2023-10-01" @default.
• W2185652955 title "A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome" @default.
• W2185652955 cites W124943251 @default.
• W2185652955 cites W1885335952 @default.
• W2185652955 cites W1905339949 @default.
• W2185652955 cites W1996642272 @default.
• W2185652955 cites W2003793309 @default.
• W2185652955 cites W2010708756 @default.
• W2185652955 cites W2039169097 @default.
• W2185652955 cites W2059639149 @default.
• W2185652955 cites W2066146080 @default.
• W2185652955 cites W2076316204 @default.
• W2185652955 cites W2085106134 @default.
• W2185652955 cites W2085177433 @default.
• W2185652955 cites W2086030126 @default.
• W2185652955 cites W2092780150 @default.
• W2185652955 cites W2106387428 @default.
• W2185652955 cites W2107443834 @default.
• W2185652955 cites W2112830170 @default.
• W2185652955 cites W2133272865 @default.
• W2185652955 cites W2136807547 @default.
• W2185652955 cites W2144810538 @default.
• W2185652955 cites W2148804756 @default.
• W2185652955 cites W2158879557 @default.
• W2185652955 cites W2258305291 @default.
• W2185652955 cites W2354928181 @default.
• W2185652955 doi "https://doi.org/10.1371/journal.pone.0138343" @default.
• W2185652955 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4587361" @default.
• W2185652955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26413873" @default.
• W2185652955 hasPublicationYear "2015" @default.
• W2185652955 type Work @default.
• W2185652955 sameAs 2185652955 @default.
• W2185652955 citedByCount "16" @default.
• W2185652955 countsByYear W21856529552016 @default.
• W2185652955 countsByYear W21856529552017 @default.
• W2185652955 countsByYear W21856529552018 @default.
• W2185652955 countsByYear W21856529552020 @default.
• W2185652955 countsByYear W21856529552021 @default.
• W2185652955 countsByYear W21856529552022 @default.
• W2185652955 countsByYear W21856529552023 @default.
• W2185652955 crossrefType "journal-article" @default.
• W2185652955 hasAuthorship W2185652955A5012581184 @default.
• W2185652955 hasAuthorship W2185652955A5020775570 @default.
• W2185652955 hasAuthorship W2185652955A5031919839 @default.
• W2185652955 hasAuthorship W2185652955A5039683551 @default.
• W2185652955 hasAuthorship W2185652955A5077588620 @default.
• W2185652955 hasAuthorship W2185652955A5090372922 @default.
• W2185652955 hasAuthorship W2185652955A5090684192 @default.
• W2185652955 hasBestOaLocation W21856529551 @default.
• W2185652955 hasConcept C126322002 @default.
• W2185652955 hasConcept C159641895 @default.
• W2185652955 hasConcept C203014093 @default.
• W2185652955 hasConcept C2777747828 @default.
• W2185652955 hasConcept C2778415529 @default.
• W2185652955 hasConcept C2778930706 @default.
• W2185652955 hasConcept C2779338263 @default.
• W2185652955 hasConcept C2779561371 @default.
• W2185652955 hasConcept C2780091579 @default.
• W2185652955 hasConcept C2780653079 @default.
• W2185652955 hasConcept C71924100 @default.
• W2185652955 hasConcept C90924648 @default.
• W2185652955 hasConcept C98274493 @default.
• W2185652955 hasConceptScore W2185652955C126322002 @default.
• W2185652955 hasConceptScore W2185652955C159641895 @default.
• W2185652955 hasConceptScore W2185652955C203014093 @default.
• W2185652955 hasConceptScore W2185652955C2777747828 @default.
• W2185652955 hasConceptScore W2185652955C2778415529 @default.
• W2185652955 hasConceptScore W2185652955C2778930706 @default.
• W2185652955 hasConceptScore W2185652955C2779338263 @default.
• W2185652955 hasConceptScore W2185652955C2779561371 @default.
• W2185652955 hasConceptScore W2185652955C2780091579 @default.
• W2185652955 hasConceptScore W2185652955C2780653079 @default.
• W2185652955 hasConceptScore W2185652955C71924100 @default.
• W2185652955 hasConceptScore W2185652955C90924648 @default.
• W2185652955 hasConceptScore W2185652955C98274493 @default.
• W2185652955 hasIssue "9" @default.
• W2185652955 hasLocation W21856529551 @default.
• W2185652955 hasLocation W21856529552 @default.
• W2185652955 hasLocation W21856529553 @default.
• W2185652955 hasLocation W21856529554 @default.
• W2185652955 hasLocation W21856529555 @default.
• W2185652955 hasOpenAccess W2185652955 @default.
• W2185652955 hasPrimaryLocation W21856529551 @default.
• W2185652955 hasRelatedWork W1589180913 @default.
• W2185652955 hasRelatedWork W1765855 @default.
• W2185652955 hasRelatedWork W1964669350 @default.
• W2185652955 hasRelatedWork W2042732525 @default.
• W2185652955 hasRelatedWork W2159732018 @default.

• next